Clinical Trial Update: Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a vaccine therapy to reduce cytomegalovirus events in patients with hematologic malignancies undergoing donor stem cell transplant; res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia Adult
• Acute Myeloid Leukemia Adult
• Chronic Myeloid Leukemia Accelerated Phase Bcr-abl1 Positive
• Chronic Myeloid Leukemia Chronic Phase Bcr-abl1 Positive
• Hodgkin Lymphoma
• Myelodysplastic Syndrome
• Myelofibrosis
• Non-hodgkin Lymphoma

Snippet

Sponsor: City of Hope Medical Center | Conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Adult Acute Lymphoblastic Leukemia in Remission | Phase 2 | Status: COMPLETED | Results posted: 2023-07-12